Format

Send to

Choose Destination
See comment in PubMed Commons below
PLoS One. 2013 Aug 16;8(8):e71040. doi: 10.1371/journal.pone.0071040. eCollection 2013.

HVEM gene polymorphisms are associated with sporadic breast cancer in Chinese women.

Author information

1
Department of Breast Surgery, The Third Affiliated Hospital of Harbin Medical University, Harbin, China ; Department of Immunology & Heilongjiang Provincial Key Laboratory for Infection and Immunity, Harbin Medical University, Harbin, China.

Abstract

As a costimulatory molecule, Herpesvirus entry mediator (HVEM) can bind with several costimulatory members, thus HVEM plays different roles in T cell immunity. HVEM and its ligands have been involved in the pathogenesis of various autoimmune, inflammatory diseases and tumors. In the current study, we conducted a case-control study comparing polymorphisms of HVEM and breast cancer. Subjects included 575 females with breast cancer and 604 age-matched healthy controls. Six HVEM SNPs (rs2281852, rs1886730, rs2234163, rs11573979, rs2234165, and rs2234167) were genotyped by PCR-RFLP. The results showed significant differences in genotypes and alleles between rs1886730 and rs2234167 (P<0.05). One haplotype (CTGCGG) that was associated with breast cancer was found via haplotype analysis. Our research also indicated an association between polymorphisms of HVEM and clinicopathologic features, including lymph node metastasis, estrogen receptor, progesterone receptor and P53. Our results primarily indicate that polymorphisms of the HVEM gene were associated with the risk of sporadic breast cancer in northeast Chinese females.

PMID:
23976978
PMCID:
PMC3745383
DOI:
10.1371/journal.pone.0071040
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Public Library of Science Icon for PubMed Central
    Loading ...
    Support Center